COVID-19 and Influenza Deaths in Australian Children 2018-2023: A National Case Analysis

Jocelynne E McRae1, Yuanfei Anny Huang1, Mehyar Khair Baik1

  • 1National Centre for Immunisation Research and Surveillance, Westmead, NSW, Australia.

Insights

COVID-19 and influenza have similar attributable mortality rates in Australian children. Accurate data is crucial for public health strategies and vaccination policies to prevent severe respiratory virus infections.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health

Background:

  • Understanding the severity of COVID-19 and influenza in children is vital for effective public health strategies, including vaccination.
  • This study focuses on comparing mortality rates attributable to these viruses in the Australian pediatric population.

Purpose of the Study:

  • To estimate and compare the mortality rates attributed to COVID-19 (caused by SARS-CoV-2) and influenza in children under 18 years old in Australia.
  • To inform public health policies by accurately assessing the burden of these respiratory viruses.

Main Methods:

  • A case series approach was used for children hospitalized with laboratory-confirmed SARS-CoV-2 or influenza who died.
  • Data were collected from January 2020 to September 2023 for COVID-19 and seasonally from 2018 to September 2023 for influenza from eight sentinel children's hospitals.
  • An expert panel assessed the causal attribution of each virus to death, and mortality rates were calculated using national surveillance data.

Main Results:

  • Attributable in-hospital mortality proportions were 58% for COVID-19 and 79% for influenza.
  • Nearly half (47%) of attributable deaths occurred in children without pre-existing comorbidities.
  • Adjusted average annualized mortality rates per million population were 0.78 for COVID-19 and 1.06 for influenza.

Conclusions:

  • Crude mortality estimates for COVID-19 and influenza in children may overestimate severity by including non-attributable deaths.
  • Accurate, age-specific attributable mortality rates and comorbidity data are essential for developing informed vaccination policies and public health interventions.
  • This research highlights the importance of precise data for managing high-burden respiratory viruses in pediatric populations.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
51.2K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
481
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
190
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K